This association with the outcome of the patients support the recent confirmation of MMP-2 as one of the candidate cancer genes (CAN genes) by the number and nature of mutations and pathways in colorectal cancer (Sjöblom et al, 2006). The gene discussed is MMP2; the disease is cancer.